Exact Sciences to Participate in March Investor Conferences

Audio By Carbonatix

MADISON, Wis.--(BUSINESS WIRE)--Feb 24, 2025--

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

• TD Cowen Health Care Conference, Boston
  Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET

• Raymond James Institutional Investors Conference, Orlando
  Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard ® and Oncotype ® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250224892130/en/

CONTACT: Derek Leckow

Exact Sciences Corp.

[email protected]

608-893-0009

KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN MASSACHUSETTS FLORIDA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES HEALTH ONCOLOGY

SOURCE: Exact Sciences Corp.

Copyright Business Wire 2025.

PUB: 02/24/2025 06:00 AM/DISC: 02/24/2025 05:59 AM

http://www.businesswire.com/news/home/20250224892130/en